Kuuhubb Provides Corporate Update and Announces Closing of US$1.3M Non-Convertible Debenture Financing
Kuuhubb Inc., a mobile game development and publishing company focused on providing the female audience with creative interactive gaming experiences, has provided the following corporate update to shareholders: Closing of Non-Convertible Debenture FinancingKuuhubb has closed the previously announced non-convertible debenture financing (the “Offering”) for aggregate gross proceeds of US$1,300,000 on a non-brokered basis. The Offering is … Continue reading Kuuhubb Provides Corporate Update and Announces Closing of US$1.3M Non-Convertible Debenture Financing Continue Reading
The Herzfeld Caribbean Basin Fund, Inc. announced that the Fund has made the following distribution pursuant to the Fund’s managed distribution plan (the “Plan”): Declaration Date Ex-Date Record Date Payment Date Per Share 09/08/2020 09/17/2020 09/18/2020 09/30/2020 $0.15525 The primary purpose of the Plan is to provide stockholders with a constant, but not guaranteed, fixed … 
Cancer Genetics, Inc. concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer … 
Revival Gold Inc., a growth‐focused gold exploration and development company, announces the nomination of Ms. H. Maura Lendon to stand for election as an independent director to Revival Gold’s Board of Directors at the Company’s annual general and special meeting to be held on November 24th, 2020 at 10:00 am ET. Ms. Lendon, LL.B, MBA, LL.M, ICD.D, … 
Halper Sadeh LLP, a global investor rights law firm, is investigating: Akcea Therapeutics, Inc. concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ionis Pharmaceuticals, Inc. Under the terms of the agreement, Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, … 
Amarin Corporation plc announced that the trial results from Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: Final results of the EVAPORATE Trial were presented at ESC Congress 2020, the annual meeting of the European Society of Cardiology, on August 29, 2020, 9:13 am CEST (Central European Summer Time) … 
VYNE Therapeutics Inc. announced that its novel ZILXI™ (minocycline) topical foam, 1.5% is available as of today, October 1, 2020 by prescription for the treatment of inflammatory lesions of rosacea in adults. Approved by the U.S. Food and Drug Administration (FDA) in May 2020, ZILXI is the first minocycline product of any form to be … 
The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Nikola Corporation on behalf of those who purchased or otherwise acquired Nikola securities between March 3, 2020 and September 20, 2020, inclusive (the “Class Period”). According to the complaint, Nikola operates as an integrated zero emissions transportation …